2023, Angina and Sudden Cardiac Death

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2023

Angina

Sudden Cardiac Death

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

JANUARY 23, 2024

21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and sudden cardiac death among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22 J Am Coll Cardiol.

Cardiovascular Disease

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease

The “open data” movement runs aground on FOURIER

Dr. Anish Koka

JANUARY 18, 2023

There was no difference in cardiovascular death, death from any cause. 3:36 AM ∙ Jan 15, 2023 As a brief aside: The PCSK9 inhibitor class of drugs were approved by the FDA because of trials like FOURIER, and the drug hit the US market with a list price of $14,000 / year.

Document

Document Academic Heart attacks Heart Attack

Cardiovascular Update

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

The “open data” movement runs aground on FOURIER

Stay Connected